Reprogramming of fibroblasts from older women with pelvic floor disorders alters cellular behavior associated with donor age

Stem Cells Translational Medicine

Volumn 2, Issue 2, 2013, Pages 118-128

  Wen, Yan ^a   Wani, Prachi ^a   Zhou, Lu ^a,b   Baer, Tom ^c   Phadnis, Smruti Madan ^a   Reijo Pera, Renee A ^a   Chen, Bertha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHENZHEN CHILDREN'S HOSPITAL   (China)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Induced pluripotent stem cells; p53; Reprogramming

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ALPHA SMOOTH MUSCLE ACTIN; BETA GALACTOSIDASE; KRUPPEL LIKE FACTOR 4; LENTIVIRUS VECTOR; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN BAX; PROTEIN P21; PROTEIN P53; STAGE SPECIFIC EMBRYO ANTIGEN 3; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONIC STEM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HYSTERECTOMY; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LENTIVIRUS INFECTION; MITOSIS INDEX; MITOSIS RATE; MOUSE; NONHUMAN; PELVIC ORGAN PROLAPSE; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SPECTRAL KARYOTYPING; TERATOMA; URINE INCONTINENCE; WESTERN BLOTTING;

EID: 84876510985     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0092     Document Type: Article

References (43)

1. Rortveit G, Daltveit AK, Hannestad YS et al. Urinary incontinence after vaginal delivery or cesarean section. New Engl J Med 2003;348: 900-907.
2. Olsen AL, Smith VJ, Bergstrom JO et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-506.
3. Nikolavasky D, Stangel-Wjcikiewicz K, Stec M et al. Stem cell therapy: A future treatment of stress urinary incontinence. Semin Reprod Med 2011;29:61-70.
4. Staack A, Rodrguez L. Stem cells for the treatment of urinary incontinence. Curr Urol Rep 2011;12:41-46.
5. Herschom S, Carr LK, Birch C. Autologous muscle-derived cells as therapy for stress urinary incontinence: A randomized blinded trial. Neurourol Urodyn 2010;29:243-326.
6. Corcos J, Loutochin O, Campeau L et al. Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence. Neurourol Urodyn 2011;30:447-455.
7. Jack G, Almeida F, Zhang R et al. Processed lipoaspirate cells for tissue engineering of the lower urinary tract: Implications for the treatment of stress urinary incontinence and bladder reconstruction. J Urol 2005;174:2041-2045.
8. Kim S-O, Na H, Kwon D et al. Bone-marrow-derived mesenchymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model. Urol Int 2011;86:110-116.
9. Lin G, Wang G, Banie L et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy 2010;12: 88-95.
10. Rodríguez L, Alfonso Z, Zhang R et al. Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci USA 2006;103:12167-12172.
11. Zeng X, Jack G, Zhang R. Treatment of sui using adipose derived stem cells: Restoration of urethral function (Abstract). J Urol 2006; 175:291.
12. Zhao W, Zhang C, Jin C et al. Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model. Eur Urol 2011;59:155-163.
13. Carr LK, Steele D, Steele S et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:881-883.
14. Chancellor MB, Yoshimura N, Pruchnic R. Gene therapy strategies for urological dysfunction. Trends Mol Med 2001;7:301-306.
15. Artandi S, Attardi L. Pathways connecting telomeres and p53 in senescence, apoptosis, and cancer. Biochem Biophys Res Commun 2005;331:881-890.
16. Helmbold H, Deppert W, Bohn W. Regulation of cellular senescence by rb2/p130. Oncogene 2006;25:5257-5262.
17. Vousden K. Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 2002;1602:47-59.
18. Atadja P, Wong H, Garkavtsev I et al. Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci USA 1995;92:8348-8352.
19. Stolzing A, Jones E, McGonagle D. Agerelated changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev 2008;129: 163-173.
20. Prigione A, Hossini A, Lichtner B et al. Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations. PLoS One 2011;6: e27352.
21. Lapasset L, Milhavet O, Prieur A et al. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev 2011;25:2248-2253.
22. Chen H-T, Lee M-J, Chen C-H et al. Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. J Cell Mol Med 2012;16:582-593.
23. Medri L, Volpi A, Nanni O et al. Prognostic relevance of mitotic activity in patients with node-negative breast cancer. Mod Pathol 2003;16:1067-1075.
24. Wen Y, Zhao Y-Y, Polan ML et al. Effect of relaxin on TGF-beta1 expression in cultured vaginal fibroblasts from women with stress urinary incontinence. Reprod Sci 2008;15:312-320.
25. Chen B, Wen Y, Yu X et al. Elastin metabolism in pelvic tissues: Is it modulated by reproductive hormones? Am J Obstet Gynecol 2005; 192:1605-1613.
26. Mostoslavsky G, Fabian A, Rooney S et al. Complete correction of murine artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc Natl Acad Sci USA 2006; 103:16406-16411.
27. Sommer C, Sommer A, Longmire T et al. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. STEM CELLS 2010;28:64-74.
28. Togo S, Sato T, Sugiura H et al. Differentiation of embryonic stem cells into fibroblastlike cells in three-dimensional type I collagen gel cultures. In Vitro Cell Dev Biol Anim 2011; 47:114-124.
29. Byrne J, Nguyen H, Reijo Pera RA. Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One 2009;4:e7118-e7118.
30. Wen Y, Man WC, Sokol ER et al. Is alpha2- macroglobulin important in female stress urinary incontinence? Hum Reprod 2008;23:387-393.
31. Nguyen H, Reijo Pera R. Metaphase spreads and spectral karyotyping of human embryonic stem cells. CSH Protoc 2008;2008: pdb.prot5047.
32. Smith Z, Nachman I, Regev A. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat Biotechnol 2010;28:521-526.
33. Wen Y, Ho J, Polan M et al. Expression of apoptotic factors in vaginal tissues from women with urogenital prolapse. Neurourol Urodyn 2011;30:1627-1632.
34. Ohmine S, Squillace K, Hartjes K et al. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging 2012;4:60-73.
35. Prigione A, Fauler B, Lurz R et al. The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. STEM CELLS 2010;28:721-733.
36. Feng Q, Lu S-J, Klimanskaya I et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. STEM CELLS 2010;28: 704-712.
37. Zhang J, Wilson GF, Soerens AG et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009;104:e30-e41.
38. Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-9367.
39. Geigl J, Langer S, Barwisch S et al. Analysis of gene expression patterns and chromosomal changes associated with aging. Cancer Res 2004;64:8550-8557.
40. Kaji K, Ohta T, Horie N et al. Donor age reflects the replicative lifespan of human fibroblasts in culture. Human Cell 2009;22:38-42.
41. Asumda F, Chase PB. Age-related changes in rat bone-marrow mesenchymal stem cell plasticity. BMC Cell Biol 2011;12: 44-44.
42. Rando T. Stem cells, ageing and the quest for immortality. Nature 2006;441:1080-1086.
43. Zhou S, Greenberger JS, Epperly MW et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008;7:335-343.